SCHEMBL28882579

SCHEMBL28882579

CCOC(=O)c1ccc(Oc2ccc(O)cn2)cc1Oc1ccc(O)cn1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CA12 O43570 3/20 0.48
▸ CA1 P00915 3/20 0.48
▸ CA2 P00918 3/20 0.48
▸ CA7 P43166 3/20 0.48
▸ CA9 Q16790 3/20 0.48
▸ CA14 Q9ULX7 3/20 0.48
▸ PDE4B Q07343 2/20 0.47
▸ MEN1 O00255 1/20 0.43
▸ LMNA P02545 1/20 0.43
▸ TP53 P04637 1/20 0.43
▸ KMT2A Q03164 1/20 0.43
▸ HSD17B10 Q99714 1/20 0.43
▸ F10 P00742 1/20 0.43
▸ PTGS2 P35354 1/20 0.41
▸ MAPT P10636 4/20 0.40
▸ GAA P10253 2/20 0.40
▸ KDM4E B2RXH2 1/20 0.40
▸ CYP1A2 P05177 2/20 0.39
▸ ESR1 P03372 1/20 0.39
▸ ESR2 Q92731 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17869112 0.81 ESR1 (0.59) CA12CA1CA2CA7CA9
SCHEMBL2235142 0.81 PDE4B (0.53) CA12CA1CA2CA7CA9
SCHEMBL30230119 0.72 L3MBTL1 (0.54) MEN1LMNAKMT2AGAAKDM4E
SCHEMBL25355195 0.71 KDM4E (0.47) MEN1LMNATP53KMT2AHSD17B10
SCHEMBL2233139 0.71 GRM2 (0.38) PDE4BMEN1KMT2AKDM4EGRM2
SCHEMBL18049818 0.71 CA12 (0.59) CA12CA1CA2CA7CA9
SCHEMBL1546951 0.70 KMT2A (0.57) CA12CA1CA2CA7CA9
SCHEMBL9364620 0.70 LMNA (0.51) MEN1LMNAKMT2AHSD17B10MAPT
SCHEMBL15268626 0.70 PTGS2 (0.61) PDE4BMEN1TP53KMT2AHSD17B10
SCHEMBL19362950 0.69 PDE4B (0.58) CA12CA1CA2CA7CA9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-107406451-B Pyrrolopyrimidines and pyrazolopyrimidines as ubiquitin-specific protease 7 inhibitors 福马治疗股份有限公司 2019-12-17 — — CN disclosed
Send feedback